Erratum: Consumption Is Increasing in India (Clinical Infectious Diseases(2016) 62 (1050-1052) DOI: 10.1093/cid/ciw055);Faropenem Consumption is Increasing in India

Clinical Infectious Diseases

Volumn 62, Issue 8, 2016, Pages 1050-1052

  Gandra, Sumanth ^a   Klein, Eili Y ^c,d   Pant, Suraj ^d   Malhotra Kumar, Surbhi ^f   Laxminarayan, Ramanan ^a,b,e  

^a Center for Disease Dynamics Economics and Policy   (India)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Economics and Policy   (United States)

^e PRINCETON UNIVERSITY   (United States)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; FROPENEM; ANTIINFECTIVE AGENT; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; DRUG USE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; HUMAN; INDIA; LETTER; PRIORITY JOURNAL; BACTERIAL INFECTIONS; DRUG UTILIZATION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE; DRUG UTILIZATION; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS;

EID: 84964886883     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix299     Document Type: Erratum

References (6)

1. Gelband H, Miller-Petrie M, Pant S, et al. The state of the world's antibiotics, 2015. Washington: Center for Disease Dynamics, Economics & Policy, 2015.
2. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
3. Gettig JP, Crank CW, Philbrick AH. Faropenem medoxomil. Ann Pharmacother 2008; 42:80-90.
4. Central Drugs Standard Control Organization. List of approved drug from 01.01.2010 to 31.12.2010. Available at: http://www.cdsco.nic.in/writereaddata/LIST-OF-APPROVED-DRUG-FROM-01-01-2010-TO-31-12-2010.pdf. Accessed 16 January 2016.
5. Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14:742-50.
6. Day KM, Pike R, Winstanley TG, et al. Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae. J Clin Microbiol 2013; 51:1881-6.